Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Kalra, Sanjay; Aamir, AH; Raza, Abbas; Das, AK; Azad Khan, AK; Shrestha, Dina; Faisal Qureshi, Md; Fariduddin, Md; Faruque Pathan, Md; Jawad, Fatema; Bhattarai, Jyoti; Tandon, Nikhil; Somasundaram, Noel; Katulanda, Prasad; Sahay, Rakesh; Dhungel, Sanjib; Bajaj, Sarita; Chowdhury, Subhankar; Ghosh, Sujoy; V. Madhu, S.; Ahmed, Tofail; Bulughapitiya, Uditha

doi:10.4103/2230-8210.163171

Public

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Published in Indian Journal of Endocrinology and Metabolism • Jan 1, 2015

Authors:

Sanjay Kalra

AH Aamir

Abbas Raza

Abstract

Since their introduction in clinical practice in the 1950's, Sulfonylureas (SUs) have remained the main-stay of pharmacotherapy in the management of type 2 diabetes. Despite their well-established benefits, their place in therapy is inappropriately being overshadowed by newer therapies. Many of the ...

Subject

Medicine

Intensive care medicine

Glimepiride

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!